In ccRCC specifically, glutamine depletion by tumor cells leads to the activation of HIF1α in infiltrating macrophages, thereby promoting IL-23 secretion and contributing to poor clinical outcomes [74]. This evidence concerns the gene HIF1A and nonpapillary renal cell carcinoma.